sopsi         

Loading

M. MAURI, C. BORRI, S. BANTI, M. MINIATI - Vol. 7, Giugno 2001, num.2

Testo Bibliografia Summary Riassunto Indice

Gli stabilizzanti del tono dell’umore nel trattamento dei disturbi dello spettro bipolare
Mood stabilizers in the treatment of bipolar spectrum disorders

1 Cassano GB, McElroy S, Brady K, Nolen WA, Placidi GF. Current issues in the identification and management of bipolar spectrum disorders in "special populations". J Affect Disord 2000;59:S69-S79.

2 Black DW, Winokur G, Bell S, Nasrallah A, Hulbert J. Complicated Mania: comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry 1988; 45:232-6.

3 Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511-8.

4 Kessler RC, McGonagle KA, Zhao S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.

5 Pini S, Cassano GB, Simonini E, Savino M, Russo A, Montgomery SA. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord 1997;42:169-80.

6 Baastrup PC, Schou M. Lithium as a Prophylactic agent: its effect against recurrent depression and manic depressive psychosis. Arch Gen Psychiatry 1967;16:162-72.

7 Coppen A, Noguera R, Bailey J. Prophylactic lithium in affective disorders. Lancet 1971;2:275-9.

8 Hullin RP, McDonald R, Allsopp MNE. Prophylactic lithium in recurrent disorders. Lancet 1972;1:1044-6.

9 Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid versus gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1992;50:448-55.

10 McElroy SL, Strakowski SM, Keck PE, Tugrol KL, West SA, Lonczack HS. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995;36:187-94.

11 Maj M, Priozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Neuropharmacology 1989;98:535-8.

12 Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does Lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991;23:1-7.

13 Muller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-22.

14 Lambert PA, Venaud G. Comparative study of valpromide versus lithium in the treatment of affective disorders. Nervure 1992;5:57.

15 Bowden CL. Maintenance strategies for bipolar disorder. Presented at American Psychiatric Association Congress New York, May 1996.

16 Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980;137:782-90.

17 Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic depressive illness. Psychopharmacol (Berlin) 1981;73:95-6.

18 Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987;150:180-2.

19 Small JG, Klapper MH, Milstein V, Kellams JJ. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry. 1991;48:915-21.

20 Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992;85:114-8.

21 Dose M, Emrich HM, Cording-Tummel C, Von Zerssen D. Use of Calcium antagonists in mania. Psychoneuroendocrinology 1986;11:241-3.

22 Dubowsky SL, Franks RD. Intracellular Calcium ions in affective disorders: a review and an hypothesis. Biol Psychiatry 1983;18:781-97.

23 Hoschl C and Kozeny J. Verapamil in affective disorders: a controlled, double-blind study. Biol Psychiatry 1989;25:128-40.

24 Giannini AJ, Taraszwski R, Loiselle RH. Verapamil and lithium in maintenance therapy of manic patients. J Clin Pharmacol 1987;27:980-2.

25 Bauer MS, Whybrow PC. Rapid Cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990;47:435-40.

26 Angst J. Recurrent Brief Psychiatric Syndromes: hypomania, depression, anxiety and neurasthenia. In: Judd LL, Saletu B, Filip V (eds). Basic and Clinical Science of Mental and Addictive Disorders. Bibl Psychiatr. Basel: Karger 1997:33-8.

27 Judd LL, Rapaport MH, Paulus MP, Brown JL. Subsyndromal symptomatic depression: a new mood disorder? J Clin Psychiatry 1994;55:18S-28S.

28 Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, et al. Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1997;53:880-6.

29 Musetti L, Perugi G, Soriani A, Rossi V, Cassano GB, Akiskal HS. Depression before and after 65; a reexamination. Br J Psychiatry 1989;155:330-6.

30 Cassano GB, Akiskal HS, Savino M. Proposed subtype of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 1992;26:127-40.

31 Cassano GB, Dell’Osso L, Frank E, Miniati M, Fagiolini A, Shear MK, et al. The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord 1999;54:319-28.

32 Fagiolini A. Dell’Osso L, Pini S, Armani A, Bouanani S, Rucci P, et al. Validity and reliability of a new instrument for assessing mood symptomatology: the Structured Clinical Interview for Mood Spectrum (SCI-MOODS). Inter J Methods Psychiat Res 1999;8:75-86.

33 Young RC. Bipolar Mood Disorder in the elderly. Psychiatric Clin North Am 1997;20:121-36.

34 Cassano GB, Pini S, Saettoni M, Rucci P, Dell’Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry 1997;59:60-68.

35 Strakowsky SM, McElroy SL, Keck Jr PE, West SA. The co-occurrence of mania with medical other psychiatric disorders 1994. Int J Psychiatry Med;24:305-28.

36 Perugi G, Akiskal HS, Rossi L, Paiano A, Quilici C, Madaro L, et al. Chronic Mania. Family history, prior course, clinical picture and social consequences. Br J Psychiatry 1998;173:514-18.

37 Pande A, Davidson J, Greist J. A placebo-controlled study of gabapentin in social phobia. In: American College of Neuropsychopharmacology Annual Meeting, Hawaii, December 1997.